Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

AMAG Pharmaceuticals - Uncertainty Remains High Amidst Makena Expiration [Seeking Alpha]

AMAG PHARMACEUTICALS (AMAG) 
Last amag pharmaceuticals earnings: 3/4 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: amagpharma.com/investors
Company Research Source: Seeking Alpha
AMAG Pharmaceuticals - Uncertainty Remains High Amidst Makena ExpirationSummaryAMAG has seen a disappointing 2017 as investors worry about the patent expiration of Makena.AMAG´s other two drugs see steady growth, but that is not sufficient to offset the anticipated pain from the loss of exclusivity of Makena.Intrarosa debut sales look soft, but it is still early in the game.After the company deleveraged and shares were under pressure in 2017, I am not still not seeing compelling reasons to buy the shares, awaiting more information in the coming quarters. Show less Read more
Impact Snapshot
Event Time:
AMAG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AMAG alerts
Opt-in for
AMAG alerts

from News Quantified
Opt-in for
AMAG alerts

from News Quantified